Insights from the Oxford Nanopore Sydney User Group

Mar 9, 2026

The shift from scientific capability to clinical reality requires a community that leans in. We recently had the privilege of exploring this at the Oxford Nanopore Technologies (ONT) Sydney User Group Meeting, held ahead of the Pathology Update and APOS 26 conferences.

What stands out most is that clinical adoption is no longer a goal, it is happening. We are seeing a profound surge in engagement from clinicians and pathology experts who are actively integrating genetic testing into their daily workflows.

Highlights from the Front Lines:

  • Real-World Application: Sebastian Lunke from VCGS demonstrated how nanopore sequencing is being applied in live diagnostic and research settings.
  • Data that Matters: Dr. Natalie Thorne from Genomical provided a clear roadmap on why data integrity and seamless systems are the backbone of clinical success.
  • Rapid Action: Dr. Jonathan Edgeworth shared updates from the UK NHS respiratory metagenomic network, proving that rapid sequencing guides faster treatment decisions and directly reduces antimicrobial resistance.

A sincere thank you to the Oxford Nanopore team for the invitation and to the experts across Australia and the UK who are demonstrating how genetic testing solves our most complex clinical challenges.

Looking ahead: We look forward to connecting with many of you over the coming days at Path Update.